Immunomodulation and sepsis: Impact of the pathogen

Shock

Volumn 22, Issue 4, 2004, Pages 297-308

  Moine, Pierre ^a   Abraham, Edward ^a  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

Author keywords

Immune responses; Inflammatory responses; Pathogenicity; Pseudomonas aeruginosa; Streptococcus pneumoniae; Virulence

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VIRULENCE FACTOR;

ADAPTATION; ANTIGEN RECOGNITION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; COEVOLUTION; EFFECTIVE POPULATION SIZE; ERADICATION THERAPY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION; INFLAMMATION; INOCULUM SIZE; MICROORGANISM; MULTIPLE ORGAN FAILURE; PATHOGENICITY; PHENOTYPIC VARIATION; PSEUDOMONAS AERUGINOSA; REVIEW; SEPSIS; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

HUMANS; NF-KAPPA B; PSEUDOMONAS AERUGINOSA; SEPSIS; STREPTOCOCCUS PNEUMONIAE; TRANSCRIPTION FACTORS; VIRULENCE FACTORS;

EID: 7944234087     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000140663.80530.73     Document Type: Review

References (130)

1. Hornef MW, Wick MJ, Rhen M, Normack S: Bacterial strategies for overcoming host innate and adaptative immune responses. Nature Immunol 3:1033-1040, 2002.
2. Oberholzer A, Oberholzer C, Moldawer LL: Sepsis syndromes: Understanding the role of innate and acquired immunity. Shock 16:83-96, 2001.
3. Wang JE, Dahle MK, McDonald M, Foster SJ, Aasen AO, Thiemermann C: Peptidoglycan and lipoteichoic acid in gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism. Shock 20:402-414, 2003.
4. Alonso de Velasco E, Verheul AFM, Snippe H: Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev 59:591-603, 1995.
5. Cundell D, Masure HR, Tuomanen EI: The molecular basis of pneumococcal infection: a hypothesis. Clin Infect Dis 21:S204-S212, 1995.
6. Houldsworth S, Andrew PW, Mitchell TJ: Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun 62:1501-1503, 1994.
7. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A: Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62:2715-2721, 1994.
8. Simpson SQ, Singh R, Bice DE: Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-alpha production by murine macrophages. Am J Respir Cell Mol Biol 10:284-289, 1994.
9. Riesenfeld-Orn I, Wolpe S, Garcia-Bustos JF, Hoffmann MK, Tuomanen E: Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun 57:1890-1893, 1989.
10. Cockeran R, Durandt C, Feldman C, Mitchell TJ, Anderson R: Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis 186:562-565, 2002.
11. Colino J, Snapper CM: Two distinct mechanisms for induction of dendritic cell apoptosis in response to intact Streptococcus pneumoniae. J Immunol 171:2354-2365, 2003.
12. Tuomanem EI: The biology of pneumococcal infection. Pediatr Res 42:253-258, 1997.
13. Ren B, Szalai AJ, Hollingshead SK, Briles DE: Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun 72:114-122, 2004.
14. Gillepsie SH, Balakrishnan I: Pathogenesis of pneumococcal infection. J Med Microbiol 49:1057-1067, 2000.
15. Cockeran R, Anderson R, Feldman C: The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis 15:235-239, 2002.
16. Jedrzejas MJ: Pneumococcal virulence factors: Structure and function. Microbiol Mol Biol Rev 65:187-207, 2001.
17. Blue CE, Paterson GK, Kerr AR, Berge M, Claverys JP, Mitchell TJ: ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract. Infect Immun 71:4925-4935, 2003.
18. Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S: Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hie protein that binds to short consensus repeats 8-11 of factor H. J Immunol 168:1886-1894, 2002.
19. Duthy TG, Ormsby RJ, Giannakis E, Ogunniyi AD, Stroeher UH, Paton JC, Gordon DL: The human complement regulator factor H binds pneumococcal surface protein PspC via short consnsus repeats 13 to 15. Infect Immun 70:5604-5611, 2002.
20. Ren B, Szalai AJ, Thomas A, Hollingshead SK, Briles DE: Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae. Infect Immun 71:75-85, 2003.
21. Balachandran P, Hollingshead SK, Paton JC, Briles DE: The autolytic anzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J Bacteriol 183:3108-3116, 2001.
22. Feldman C, Anderson R, Coskeran R, Mitchell T, Cole P, Wilson R: The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro. Respir Med 96:580-585, 2002.
23. Pericone CD, Park S, Imlay JA, Weiser JN: Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (SpxB) and avoidance of the toxic effects of the fenton reaction. J Bacteriol 185:6815-6825, 2003.
24. Van Delden C, Iglewski BH: Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4:551-560, 1998.
25. Rumbaugh KP, Griswold JA, Hamood AN: The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa. Microbes Infect 2:1721-1731, 2000.
26. De Kievit TR, Iglewski BH: Bacterial quorum sensing in pathogenic relationships. Infect Immun 68:4839-4849, 2000.
27. Smith RS, Iglewski BH: P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 6:56-60, 2003.
28. Muller S, Feldman MF, Cornelis GR: The type III secretion system of gram negative bacteria: a potential therapeutic target? Expert Opin Ther Targets 5:327-339, 2001.
29. Schulen GS, Feltman H, Rabin SD, Martin CG, Battle SE, Rello J, Hauser AR: Secretion of the toxin Exo U is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 188:1695-1706, 2003.
30. Smith RS, Iglewski B: Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J Clin Invest 112:1460-1465, 2003.
31. Polissi A, Pontiggia A, Feger G, Altieri M, Mottl H, Ferrari L, Simon D: Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 66:5620-5629, 1998.
32. Hava DL, Camilli A: Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45:1389-1406, 2002.
33. Wolfgang MC, Kulasekara BR, Liang X, Boyd D, Yang Q, Miyada CG, Lory S: Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 100:8484-8489, 2003.
34. Berry AM, Paton JC: Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 68:133-140, 2000.
35. Weiser JN, Austrian R, Sreenivasan PK, Masure HR: Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 62:2582-2589, 1994.
36. Cundell DR, Tuomanem EI: Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocyte and vascular endothelial cells in vitro. Microb Pathog 17:361-374, 1994.
37. Kim JO, Weiser JN: Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with virulence of Streptococcus pneumoniae. J Infect Dis 177:368-377, 1998.
38. Long JP, Tong HH, Shannon PA, DeMaria TF: Differential expression of cytokine genes and inducible nitric oxide synthase induced by opacity phenotype variants of Streptococcus pneumoniae during acute otitis media in the rat. Infect Immun 71:5531-5540, 2003.
39. Weiser JN: Phase variation of Streptococcus pneumoniae. In Fischetti VA, et al. (eds.): Cram-Positive Pathogens. Washington, DC: American Society for Microbiology, pp 225-231, 2000.
40. Overweg K, Pericone CD, Verhoef GG, Weiser JN, Meiring HD, De Jong AP, De Groot R, Hermans PW: Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect Immun 68:4604-4610, 2000.
41. Ogunniyi AD, Giammarinaro P, Paton JC: The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiol 148:2045-2053, 2002.
42. Donabedian H: Quorum sensing and its relevance to infectious diseases. J Infect 46:207-214, 2003.
43. Cvitkovitch DG, Li YH, Ellen RP: Quorum sensing and biofilm formation in streptococcal infections. J Clin Invest 112:1626-1632, 2003.
44. Yarwood JM, Schlievert PM: Quorum sensing in Staphylococcus infections. J Clin Invest 112:1620-1625, 2003.
45. Stroeher UH, Paton AW, Ogunniyi D, Paton JC: Mutation of luxC of Streptococcus pneumoniae affects virulence in a mouse model. Infect Immun 71:3206-3212,2003.
46. Tomasz A: Control of the component state in pneumococcus by a hormone-like cell product: an example for a new type of regulatory mechanism in bacteria. Nature 208:155-159, 1965.
47. Knodle LA, Celli J, Finlay BB: Pathogenic trickery: deception of host cell processes. Nature Rev 2:578-588, 2001.
48. Goehring UM, Schmidt G, Pederson KJ, Aktories K, Barbieri JT: The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for rho GTPases. J Biol Chem 274:36369-36372, 1999.
49. Cowell BA, Chen DY, Frank DW, Vallis AJ, Fleiszig SM: ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells. Infect Immun 68:403-406, 2000.
50. Celli J, Finlay BB: Bacterial avoidance of phagocytosis. Trends Microbiol 10:232-237, 2002.
51. Rosenberger CM, Finlay BB: Phagocyte sabotage: disruption of macrophage signaling by bacterial pathogens. Nat Rev Mol Cell Biol 4:385-396, 2003.
52. Sundin C, Hallberg B, Forsberg A: ADP-ribosylation by exoenzyme T of Pseudomonas aeruginosa induces an irreversible effect of the host cell cytoskeleton in vivo. FEMS Microbiol Lett 234:87-91, 2004.
53. Mileski W, Harlan J, Rice C, Winn R: Streptococcus pneumoniae-stimulated macrophages induce neutrophils to emigrate by a CD-18-independent mechanism of adherence. Circ Shock 31:259-267, 1990.
54. Rogers PD, Thornton J, Barker KS, McDaniel DO, Sacks GS, Swiatlo E, McDaniel LS: Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of TPH-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun 71:2087-2094, 2003.
55. Rubins JB: Pomeroy CI: Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun 65:2975-2977, 1997.
56. DiMango E, Zar HJ, Bryan R, Prince A: Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 96:2204-2210, 1995.
57. Epelman S, Neely GG, Ma LL, Gjomarkal M, Pace E, Melis M, Woods DE, Mody CH: Distinct fates of monocytes and T cells directly activated by Pseudomonas aeruginosa exoenzyme S. J Leukoc Biol 71:458-468, 2002.
58. Denning GM, Wollenweber LA, Railsback MA, Cox CD, Stoll LL, Britigan BE: Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun 66:5777-5784, 1998.
59. Mori N, Oishi K, Sar B, Mukaida N, Nagatake T, Matsushima K, Yamamoto N: Essential role of transcription factor nuclear factor kappaB in regulation of interleukin-8 gene expression by nitrite reductase from Pseudomonas aeruginosa in respiratory epithelial cells. Infect Immun 67:3872-3878, 1999.
60. Cusumano V, Tufano MA, Mancuso G, Carbone M, Rossano F, Fera MT, Ciliberti FA, Ruocco E, Merendino RA, Teti G: Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes. Infect Immun 65:1683-1687, 1997.
61. Smith RS, Harris SG, Phipps R, Iglewski B: The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl) homoserine lactone contributes to virulence and induces inflammation in vivo. J Bacteriol 184:1132-1139, 2002.
62. McMorran B, Town L, Costelloe E, Palmer J, Engel J, Hume D, Wainwright B: Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection. Infect Immun 71:6035-6044, 2003.
63. Lagoumintzis G, Christofidou M, Dimitracopoulos G, Paliogianni F: Pseudomonas aeruginosa slime glycoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor κB and activator protein I in human monocytes. Infect Immun 71:4614-4622, 2003.
64. Wieland CW, Siegmund B, Senaldi G, Vasil ML, Dinareilo CA, Fantuzzi G: Pulmonary inflammation induced by Pseudomomas aeruginasoa lipopolysaccharide, phospholipase C and exotoxin A: role of Interferon regulatory factor 1. Infect Immun 70:1352-1358, 2002.
65. Zhang J, Xu K, Ambati B, Yu FSX: Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest Ophthalmol Vis Sci 44:4247-4254, 2003.
66. Horvat RC, Parmely MJ: Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity. Infect Immun 56:2925-2932, 1988.
67. Parmely M, Gale A, Clabaugh M, Horvat R, Zhou WW: Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect Immun 58:3009-3014, 1990.
68. Theander TG, Kharazmi A, Petersen BK, Christensen LD, Tvede N, Poulsen LK, Odum N, Svenson M, Bendtzen K: Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases. Infect Immun 56:1673-1677, 1988.
69. Wilson M, Seymour R, Henderson B: Bacterial perturbation of cytokine networks. Infect Immun 66:2401-2409, 1998.
70. Hornef MW, Wick MJ, Rhen M, Normack S: Bacterial strategies for overcoming host innate and adaptative immune responses. Nat Immunol 3:1033-1040, 2002.
71. Schultz MJ, Speelman P, Zaat SAJ, Hack CE, van Deventer SJH, van der Poll T: The effect of Pseudomonas exotoxin A on cytokine production in whole blood exposed to Pseudomonas aeruginosa. FEMS Immunol Med Microbiol 29:227-232, 2000.
72. Telford G, Wheeler D, Williams P, Tomkins PT, Appleby P, Sewell H, Stewart GS, Bycroft BW, Pritchard DL: The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activity. Infect Immun 66:36-42, 1998.
73. Bruno TF, Woods DE, Mody CH: Exoenzyme S from Pseudomonas aeruginosa induces apoptosis in T lymphocytes. J Leukoc Biol 67:808-816, 2000.
74. Tateda K, Ishii Y, Horikawa M, Matsumoto T, Miyairi S, Pechere JC, Standiford TJ, Ishiguro M, Yamaguchi K: The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect Immun 71:5785-5793, 2003.
75. Usher LR, Lawson RA, Geary I, Taylor CJ, Bingle CD, Taylor GW, Whyte MKB: Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 168:1861-1868, 2002.
76. Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, Botstein D, Staudt LM, Brown PO, Relman DA: Stereotyped and specific gene expression programs in human innate immune resposnse to bacteria. Proc Natl Acad Sci USA 99:972-977, 2002.
77. Raetz CRH, Whilfield C: Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635-700,2002.
78. Ernst RK, Eugene CY, Guo L, Lim KB, Burns JL, Hackett M, Miller SI: Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286:1561-1565, 1999.
79. Guo L, Lim KB, Poduje CM, Daniel M, Gunn JS, Hackett M, Miller SI: Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189-198, 1998.
80. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI: Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3:354-359, 2002.
81. Hessle C, Andersson B, Wold AE: Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate 1L-10 production. Infect Immun 68:3581-3586, 2000.
82. Jiang Y, Magli L, Russo M: Bacterium-dependent induction of cytokines in mononuclear cells and their pathologic consequences in vivo. Infect Immun 67:2125-2130, 1999.
83. Silverstein R, Norimatsu M, Morrison DC: Fundamental differences during gram-positive versus gram-negative sepsis become apparent during bacterial challenge of D-galactosamide-treated mice. J Endotoxin Res 4:173-181, 1997.
84. Kragsbjerg P, Soderquist B, Holmberg H, Vikerfors T, Danielsson D: Production of tumor necrosis factor-alpha and interleukin-6 in whole blood stimulated by live gram-negative and gram-positive bacteria. Clin Microbiol Infect 4:129-134, 1998.
85. Nau GJ, Schlesinger A, Richmond JFL, Young RA: Cumulative toll-like receptor activation in human macrophages treated with whole bacteria. J Immunol 170:5203-5209, 2003.
86. Ingalls RR, Rice PA, Qureshi N, Takayama K, Lin JS, Golenbock DT: The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 63:3125-3130, 1995.
87. Jotwani R, Tanaka Y, Watanabe K, Tanaka-Bandoh K, Kato N, Ueno K: Comparison of cytokine induction by lipopolysaccharide of Bacteroides fragilis with Salmonella typhimurium in mice. Microbiol Immunol 38:763-766, 1994.
88. Cavaillon JM, Haeffner-Cavaillon N: Characterization of the induction of human interleukin-1 by endotoxins. In Paubert-Braquet M (ed.): Lipid Mediators in the Immunology of Shock. NATO ASI Series 1987. Vol. 139. New York: Plenum Press, pp 395-407, 1987.
89. Zughaier SM, Ryley HC, Jackson SK: Lipopolysaccharides (LPS) from Burkholderia cepacia is more active than LPS from Paeudomonoas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 67:1505-1507, 1999.
90. Koyama S, Sato E, Nomura H, Kubo K, Miura M, Yamashita T, Nagai S, Izumi T: The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am J Physiol Lung Cell Mol Physiol 278:L658-L666, 2000.
91. Pulendran B, Kumar P, Cutler C, Mohamadzadeh M, Van Dyke T, Banchereau J: Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167:5067-5076, 2001.
92. Mohler J, Azoulay-Dupuis E, Amory-Rivier E, Mazoit JX, Bédos JP, Rieux V, Moine P: Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia. Intensive Care Med 29:808-816, 2003.
93. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dycke T, Pulendran B: Cutting edge: different toll-like receptor agonists instruct dendritic cells to induce Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171:4984-4989, 2003.
94. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, Lander ES, Hacohen N: The plasticity of dendritic cell responses to pathogens and their components. Science 294:870-875, 2001.
95. Arcaroli J, Kupfner J, Yum OK, Shenkar R, Park JS, Abraham E: Lipopolysaccharide-induced neutrophil gene expression under in vivo or in vitro conditions. Chest 121:76S, 2002.
96. Van der Poll T, Keogh CV, Buurman WA, Lowry SF: Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 155:603-608, 1997.
97. Laichalk LL, Kundel SL, Stricter RM, Danforth JM, Bailie MB, Standiford TJ: Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun 64:5211-5218, 1996.
98. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ: Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155:722-729, 1995.
99. Van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF: Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174:994-1000, 1996.
100. Schultz MJ, Rijneveld AW, Florquin S, Edwards CK, Dinarello CA, Van der Poll T: Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol 282:L285-L290, 2002.
101. Schultz MJ, Knapp S, Florquin S, Pater J, Pater J, Takeda K, Akira S, Van der Poll T: Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect Immun 71:1630-1634, 2003.
102. Kanangat S, Meduri GU, Tolley EA, Patterson DR, Meduri CU, Pak C, Griffin JP, Bronze MS, Schaberg DR: Effect of cytokines and endotoxin on the intracellular growth of bacteria. Infect Immun 67:2834-2840, 1999.
103. Porat R, Clark BD, Wolff SM, Dinarello CA: IL-1β and Escherichia coli. Science 258:1562-1563, 1992.
104. Porat R, Clark BD, Wolff SM, Dinarello CA: Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254:430, 1991.
105. Meduri GU: Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome. Crit Care 6:24-29, 2002.
106. Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D: Cytokines IL-1β, IL-6 and TNF-α enhance in vitro growth of bacteria. Am J Respir Crit Care Med 160:961-967, 1999.
107. Senftleben U, Karin M: The IKK/NF-kappa B pathway. Crit Care Med 30:S18-S26, 2002.
108. Tak PP, Firestein GS: NF-κB: a key role in inflammatory diseases. J Clin Invest 107:7-11, 2001.
109. Ulevitch RJ: New therapeutic targets revealed through investigations of innate immunity. Crit Care Med 29:58-512, 2001.
110. Zhang G, Ghosh S: Toll-like receptor-mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107:13-19, 2001.
111. Abraham E: NF-κB activation. Crit Care Med 28:N100-N104, 2000.
112. May MJ, Ghosh S: Signal transduction through NF-κB. Immunol Today 19:80-88, 1998.
113. Kopp EB, Medzhitov R: The Toll-receptor family and control of innate immunity. Curr Opin Immunol 11:13-18, 1999.
114. Kitamura M: NF-κB-mediated self defense of macrophages faced with bacteria. Eur J Immunol 29:1647-1655, 1999.
115. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT: Recognition of pneumolysin by toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 100:1966-1971, 2003.
116. Spellerberg B, Rosenow C, Sha W, Tuomanen EI: Pneumococcal cell wall activates NF-kB in human monocytes: aspects distinct from endotoxin. Microb Pathog 20:309-317, 1996.
117. Tato CM, Hunter CA: Host-pathogen interactions: Subversion and utilization of NF-κB pathway during infection. Infect Immun 70:3311-3317, 2002
118. Sha WC, Liou HC, Tuomanem EI, Baltimore D: Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330, 1995.
119. Whyte MK, Meagher LC, MacDermot J, Haslett C: Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 150:5124-5134, 1993.
120. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C: Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83:865-875, 1989.
121. 2, and PAF. J Clin Invest 101:890-898, 1998.
122. 2. J Leukoc Biol 52:269-273, 1992.
123. Weinrauch Y, Zychlinsky A: The induction of apoptosis by bacterial pathogens. Annu Rev Microbiol 53:155-187, 1999.
124. Grassmé H, Jendrossek V, Gulbins E: Molecular mechanisms of bacteria induced apoptosis. Apoptosis 6:441-445, 2001.
125. Ran H, Hassett DJ, Lau GW: Human targets of Pseudomonas aeruginosa pyocyanin. Proc Natl Acad Sci USA 100:14315-14320, 2003.
126. 2 mediate brain cell apoptosis during meningitis. J Clin Invest 109:19-27, 2002.
127. Grassmé H, Kirschnek S, Riethmueller J, Riehle A, von Kürthy G, Lang F, Weller M, Gulbins E: CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science 290:527-530, 2000.
128. Wahl C, Oswald F, Simnacher U, Weiss S, Marre R, Essig A: Survival of Chlamydia pneumoniae-infected mono mac 6 cells is dependent on NF-κB binding activity. Infect Immun 69:7039-7045, 2001.
129. van Zandbergen G, Gieffers J, Kothe H, Rupp J, Bollinger A, Aga E, Klinger M, Brade H, Dalhoff K, Maass M, Solbach W, Laskay T: Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol 172:1768-1776, 2004.
130. Gray ML, Killinger AH: Listeria monocytogenes and listeric infections. Bacteriol Rev 30:309-382, 1996.